FDA sees promise in Web-scale pharmacovigilance

10/29/2013 | CNBC

The FDA is showing interest in Web-scale pharmacovigilance, the use of data from online searches to find possible adverse drug interactions and events. "This data has proven useful for similar health-related purposes such as disease detection and outbreak surveillance, so we are cautiously optimistic there will be value in the post-market safety setting, while also preparing for unique challenges involved in analyzing these data," FDA spokeswoman Andrea Fischer said.

View Full Article in:

CNBC

Published in Brief: